All 1 tracked stories fall under one category: pharma. Of the tracked stories, 1 of 1 also mention CosmoFarm S.A., the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Biotech story that mention bio-bebe, all published on July 25, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about bio-bebe
All 1 tracked stories fall under one category: pharma. Of the tracked stories, 1 of 1 also mention CosmoFarm S.A., the most common co-covered peer. Each carries 2 original sources on average. We currently track 1 Biotech story that mention bio-bebe, all published on July 25, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 15 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering bio-bebe. Shared-story counts are live from our verified record — not editorial picks.
Cosmos Health's pharma wholesale arm CosmoFarm achieved a record $15M+ in Q2 2026, reaching a $60M annualized run-rate. The addition of over 80 pharmacies and investments in AI-driven automation aim to enhance margins and scalability, positioning CosmoFarm as a key growth driver in the biotech/pharma sector.